1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride is primarily utilized in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting central nervous system disorders. Its trifluoromethyl groups enhance the lipophilicity and metabolic stability of the resulting molecules, making it valuable in designing drugs with improved bioavailability and efficacy. Additionally, this compound is employed in the preparation of ligands for receptor studies, aiding in the exploration of neurological pathways and potential therapeutic targets. Its role in medicinal chemistry underscores its importance in advancing drug discovery and development processes.